CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 32753 [2016-12224]

Download as PDF Federal Register / Vol. 81, No. 100 / Tuesday, May 24, 2016 / Notices accordance with law, the Receiver will be making a final dividend payment to proven creditors. Based upon the foregoing, the Receiver has determined that the continued existence of the receivership will serve no useful purpose. Consequently, notice is given that the receivership shall be terminated, to be effective no sooner than thirty days after the date of this Notice. If any person wishes to comment concerning the termination of the receivership, such comment must be made in writing and sent within thirty days of the date of this Notice to: Federal Deposit Insurance Corporation, Division of Resolutions and Receiverships, Attention: Receivership Oversight Department 34.6, 1601 Bryan Street, Dallas, TX 75201. No comments concerning the termination of this receivership will be considered which are not sent within this time frame. Date: May 19, 2016. Federal Deposit Insurance Corporation. Robert E. Feldman, Executive Secretary. FEDERAL ELECTION COMMISSION Sunshine Act Meetings Federal Election Commission. & TIME: Thursday, May 19, 2016 at 10:00 a.m. PLACE: 999 E Street, NW., Washington, DC (ninth floor). STATUS: This meeting will be open to the public. Federal Register Notice of Previous Announcement—81 FR 30304. The Following Item Was Also Discussed: REG 2014–01 Outline of Draft NPRM Implementing Party Segregated Accounts. PERSON TO CONTACT FOR INFORMATION: Judith Ingram, Press Officer, Telephone: (202) 694–1220. AGENCY: DATE Shawn Woodhead Werth, Secretary and Clerk of the Commission. [FR Doc. 2016–12298 Filed 5–20–16; 11:15 am] BILLING CODE 6715–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2016–12180 Filed 5–23–16; 8:45 am] BILLING CODE 6714–01–P Centers for Disease Control and Prevention FEDERAL ELECTION COMMISSION CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment Sunshine Act Meetings Federal Election Commission. & TIME: Thursday, May 26, 2016 at 10:00 a.m. PLACE: 999 E Street NW., Washington, DC (Ninth Floor). STATUS: This meeting will be open to the public. ITEMS TO BE DISCUSSED: Proposed Statement of Policy Regarding the Public Disclosure of Closed Enforcement Files Management and Administrative Matters Individuals who plan to attend and require special assistance, such as sign language interpretation or other reasonable accommodations, should contact Shawn Woodhead Werth, Secretary and Clerk, at (202) 694–1040, at least 72 hours prior to the meeting date. PERSON TO CONTACT FOR INFORMATION: Judith Ingram, Press Officer, Telephone: (202) 694–1220. AGENCY: sradovich on DSK3TPTVN1PROD with NOTICES DATE Shawn Woodhead Werth, Secretary and Clerk of the Commission. [FR Doc. 2016–12248 Filed 5–20–16; 11:15 am] BILLING CODE 6715–01–P VerDate Sep<11>2014 17:24 May 23, 2016 Jkt 238001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) announce the following committee meeting. Times and Dates: 8:30 a.m.–5:30 p.m., EDT, June 14, 2016; 8:30 a.m.–3:00 p.m., EDT, June 15, 2016. Place: CDC Corporate Square, Building 8, Conference Room 1–ABC, 8 Corporate Boulevard, Atlanta, Georgia 30329, Telephone: (404) 639–8317. The meeting is also accessible by teleconference. Toll-free number +1 (877) 603–4228, Participant code: 42598858. Status: Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people. Purpose: This Committee is charged with advising the Director, CDC and the Administrator, HRSA, regarding activities related to prevention and control of HIV/AIDS, Viral Hepatitis and other STDs, the support of health care services to persons living with HIV/ AIDS, and education of health professionals and the public about HIV/ AIDS, Viral Hepatitis and other STDs. PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 32753 Matters For Discussion: Agenda items include: (1) Syphilis among Men Who Have Sex with Men (MSM) and Congenital Syphilis; (2) Update on CDC’s Medical Monitoring Project; (3) Discussion on Infectious Diseases prevention for people who inject drugs (PWID); (4) Findings of the Institute of Medicine Committee on A National Strategy for the Elimination of Hepatitis B and C: Feasible elimination goals and possible factors critical for success; and (5) Updates from Workgroups. Agenda items are subject to change as priorities dictate. Contact Person For More Information: Margie Scott-Cseh, CDC, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, 1600 Clifton Road NE., Mailstop E–07, Atlanta, Georgia 30333; telephone (404) 639– 8317. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2016–12224 Filed 5–23–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting for the aforementioned subcommittee: Time and Date 10:30 a.m.–5:00 p.m., EDT, June 14, 2016 Place: Audio Conference Call via FTS Conferencing. Status: Open to the public, but without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written E:\FR\FM\24MYN1.SGM 24MYN1

Agencies

[Federal Register Volume 81, Number 100 (Tuesday, May 24, 2016)]
[Notices]
[Page 32753]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12224]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) and the Health Resources and Services Administration 
(HRSA) announce the following committee meeting.
    Times and Dates: 8:30 a.m.-5:30 p.m., EDT, June 14, 2016; 8:30 
a.m.-3:00 p.m., EDT, June 15, 2016.
    Place: CDC Corporate Square, Building 8, Conference Room 1-ABC, 8 
Corporate Boulevard, Atlanta, Georgia 30329, Telephone: (404) 639-8317. 
The meeting is also accessible by teleconference. Toll-free number +1 
(877) 603-4228, Participant code: 42598858.
    Status: Open to the public, limited only by the space available. 
The meeting room will accommodate approximately 100 people.
    Purpose: This Committee is charged with advising the Director, CDC 
and the Administrator, HRSA, regarding activities related to prevention 
and control of HIV/AIDS, Viral Hepatitis and other STDs, the support of 
health care services to persons living with HIV/AIDS, and education of 
health professionals and the public about HIV/AIDS, Viral Hepatitis and 
other STDs.
    Matters For Discussion: Agenda items include: (1) Syphilis among 
Men Who Have Sex with Men (MSM) and Congenital Syphilis; (2) Update on 
CDC's Medical Monitoring Project; (3) Discussion on Infectious Diseases 
prevention for people who inject drugs (PWID); (4) Findings of the 
Institute of Medicine Committee on A National Strategy for the 
Elimination of Hepatitis B and C: Feasible elimination goals and 
possible factors critical for success; and (5) Updates from Workgroups.
    Agenda items are subject to change as priorities dictate.
    Contact Person For More Information: Margie Scott-Cseh, CDC, 
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, 
1600 Clifton Road NE., Mailstop E-07, Atlanta, Georgia 30333; telephone 
(404) 639-8317.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the CDC and the Agency for Toxic Substances and Disease 
Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 2016-12224 Filed 5-23-16; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.